AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 2 310-R317, Copyright © 1992 by American Physiological Society

ARTICLES

Cerebral metabolic responses and vasopressin and oxytocin secretions during progressive water deprivation in rats

M. Kadekaro, J. Y. Summy-Long, S. Freeman, J. S. Harris, M. L. Terrell and H. M. Eisenberg
Division of Neurosurgery, University of Texas Medical Branch, Galveston 77550.

Progressive water deprivation increased plasma osmolality, plasma Na+ concentration, and hematocrit in proportion to the severity of dehydration. With increases of 2% in plasma osmolality (24 h dehydration), glucose utilization increased in the supraoptic nuclei and tended to increase in the neural lobe. With further dehydration, glucose utilization also increased in the paraventricular nuclei. These increases were paralleled by depletion of vasopressin and oxytocin contents in the neural lobe and by the enhanced secretion of both hormones into plasma, with a predominant increase of vasopressin. These changes were proportional to the degree of dehydration. With progression of dehydration, decreases in intracellular and extracellular volumes accentuate. Reductions in extracellular volume result in increased angiotensin II (ANG II) formation. Accordingly, glucose utilization in the subfornical organ (SFO), a primary site of ANG II action, increased after 48 and 72 h of dehydration. The median preoptic nucleus, which receives direct inputs from the SFO, also increased glucose utilization at these times. Glucose utilization also increased in the organum vasculosum laminae terminalis, probably in response to the converging inputs from osmoreceptors, volume receptors, and ANG II receptors. Decreases in glucose utilization were observed in the caudal and rostral ventrolateral medulla, perhaps as compensatory responses to decreased extracellular volume to prevent fall in arterial blood pressure.

This article has been cited by other articles:

				I. A. Simpson, D. Dwyer, D. Malide, K. H. Moley, A. Travis, and S. J. Vannucci The facilitative glucose transporter GLUT3: 20 years of distinction Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E242 - E253. [Abstract] [Full Text] [PDF]

				L. C. Michelini, M. C. Marcelo, J. Amico, and M. Morris Oxytocinergic regulation of cardiovascular function: studies in oxytocin-deficient mice Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2269 - H2276. [Abstract] [Full Text] [PDF]

				K. T. Higa, E. Mori, F. F. Viana, M. Morris, and L. C. Michelini Baroreflex control of heart rate by oxytocin in the solitary-vagal complex Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2002; 282(2): R537 - R545. [Abstract] [Full Text] [PDF]

				L. C. MICHELINI Oxytocin in the NTS: A New Modulator of Cardiovascular Control during Exercise Ann. N.Y. Acad. Sci., June 1, 2001; 940(1): 206 - 220. [Abstract] [Full Text] [PDF]

				M. Zelenina, B. M. Christensen, J. Palmer, A. C. Nairn, S. Nielsen, and A. Aperia Prostaglandin E2 interaction with AVP: effects on AQP2 phosphorylation and distribution Am J Physiol Renal Physiol, March 1, 2000; 278(3): F388 - F394. [Abstract] [Full Text] [PDF]

				G. Nishimoto, M. Zelenina, D. Li, M. Yasui, A. Aperia, S. Nielsen, and A. C. Nairn Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue Am J Physiol Renal Physiol, February 1, 1999; 276(2): F254 - F259. [Abstract] [Full Text] [PDF]

				E. Moellenhoff, C. J. Lebrun, A. Blume, J. Culman, T. Herdegen, and T. Unger Central angiotensin AT1 and muscarinic receptors in ITF expression on intracerebroventricular NaCl Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R234 - R244. [Abstract] [Full Text] [PDF]